Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) represents the most common inherited cardiac disease and a leading cause of heart failure, arrhythmias, and sudden cardiac death in young individuals. For decades, management of HCM has relied on symptom control with β-blockers, calcium channel blockers, disopyramid...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
IMR Press
2026-01-01
|
| シリーズ: | Reviews in Cardiovascular Medicine |
| 主題: | |
| オンライン･アクセス: | https://www.imrpress.com/journal/RCM/27/1/10.31083/RCM47341 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|